NCT00654043

Bioavailability Study of Torsemide Tablets Under Fed Conditions

Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Torsemide Tablets 20mg With That of Roche Demadex 1*20 mg in Healthy Subjects Under Fed Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To compare the single-dose bioavailability of Torsemide tablets with Demadex

Detailed description

To compare the single -dose bioavailability of Par Torsemide tablets 20mg with that Roche Demadex 1\*20mg tablets under fed conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Torsemide	tablets, 20 Mg, single-dose
DRUG	Demadex	Tablets, 20 mg, single-dose

Timeline

• Start date: 2001-04-01
• Primary completion: 2001-05-01
• Completion: 2001-05-01
• First posted: 2008-04-07
• Last updated: 2008-04-11